OCUL(Ocular Therapeutix, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $43.52M | $51.49M | $58.44M | $63.72M | $51.95M |
| 毛利润 | $39.12M | $46.95M | $53.16M | $58.10M | $45.38M |
| 营业利润 | −$78.04M | −$78.65M | −$82.38M | −$171.78M | −$270.02M |
| 净利润 | −$6.55M | −$71.04M | −$80.74M | −$193.51M | −$265.94M |
| 经营现金流 | −$65.55M | −$59.60M | −$70.23M | −$134.68M | −$204.88M |
| 自由现金流 | −$66.74M | −$63.32M | −$76.32M | −$135.97M | −$216.89M |
| 摊薄每股收益 | — | $-0.97 | $-1.02 | $-1.22 | $-1.42 |